alexa Oral Antiplatelet Agents in Dialysis Patients: Friends or Foes?

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Oral Antiplatelet Agents in Dialysis Patients: Friends or Foes?

Thrombotic cardiovascular events are one of the main causes of morbidity and mortality in dialysis patients and vascular access thrombosis remains the Achilles ´ heel for patients undergoing maintenance hemodialysis (HD). HD and uremia are characterized by two simultaneous but opposite hematological abnormalities: a thrombotic predisposition and a bleeding tendency mainly due to impaired platelet-platelet and platelet-vessel wall interactions.

 
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
 
adwords